All filters
Videos
Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD
Presented at:
International Workshop on HBV Cure 2021
Videos
Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD
Presented at:
International Workshop on HBV Cure 2021
Videos
Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Biological Insights Taught by Clinical Responses to Novel Hbv/Hdv Drugs - S. Urban, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation -P. Mishra, MD
Presented at:
International Workshop on HBV Cure 2021
Videos
How to Handle Flares in HBV Trials With Novel Agents - H. Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Outcomes After NUC Therapy Discontinuation - M. Cornberg, MD
Presented at:
International Workshop on HBV Cure 2021
Videos
HBsAg Loss: A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021
Videos
HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci.
Presented at:
International Workshop on HBV Cure 2021
Videos
VBI-2601: Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Immunotherapeutics in the Treatment of Chronic Hepatitis B - S. Browne, MD
Presented at:
International Workshop on HBV Cure 2021
Videos
What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials? - A. Gehring, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
New Data From Combination Trials for Chronic Hepatitis B - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Videos
Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2021